BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20566780)

  • 1. Oral and IV contrast agents for the CT portion of PET/CT.
    Cronin CG; Prakash P; Blake MA
    AJR Am J Roentgenol; 2010 Jul; 195(1):W5-W13. PubMed ID: 20566780
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography/computed tomography: protocol issues and options.
    Blodgett TM; McCook BM; Federle MP
    Semin Nucl Med; 2006 Apr; 36(2):157-68. PubMed ID: 16517237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New negative contrast medium for PET/CT].
    Debatin J
    Rofo; 2005 Jun; 177(6):779. PubMed ID: 15902645
    [No Abstract]   [Full Text] [Related]  

  • 4. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
    Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
    Monzawa S; Adachi S; Suzuki K; Hirokaga K; Takao S; Sakuma T; Hanioka K
    Ann Nucl Med; 2009 Dec; 23(10):855-61. PubMed ID: 19876704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with a commercially available negative oral contrast medium in PET/CT.
    Hausegger K; Reinprecht P; Kau T; Igerc I; Lind P
    Rofo; 2005 Jun; 177(6):796-9. PubMed ID: 15902627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated PET/CT and cancer imaging.
    De Wever W; Coolen J; Verschakelen JA
    JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PET-CT with intravenous contrast in the evaluation of patients with lymphoma. Contribution to diagnostic indications].
    Talavera Rubio MP; García Vicente AM; Domínguez Ferreras E; Calle Primo C; Poblete García VM; Hernández Ruiz B; Bellón Guardia M; Palomar Muñoz A; Cepedello Boiso I; Pilkington Woll P; González García B; Cordero García JM; Molino Trinidad C; Soriano Castrejón A
    Rev Esp Med Nucl; 2009; 28(5):235-41. PubMed ID: 19922840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
    Kubota K; Murakami K; Inoue T; Itoh H; Saga T; Shiomi S; Hatazawa J
    Ann Nucl Med; 2011 Dec; 25(10):777-86. PubMed ID: 21901365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mandated radiologist-performed electronic order entry: effect on CT oral contrast administration.
    Davenport MS; Gardner CS; Jaffe TA
    AJR Am J Roentgenol; 2012 Mar; 198(3):616-20. PubMed ID: 22358001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. With helical CT, is nonionic contrast a better choice than ionic contrast for rapid and large IV bolus injections?
    Hopper KD
    AJR Am J Roentgenol; 1996 Mar; 166(3):715. PubMed ID: 8623657
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
    Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
    Goerres GW; Schuknecht B; Schmid DT; Stoeckli SJ; Hany TF
    Clin Imaging; 2008; 32(6):431-7. PubMed ID: 19006770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnographic research of IV contrast agent in hospital CT scanning suites.
    Hollot B; Bullano KH
    Radiol Manage; 2010; 32(4):30-8; quiz 40-1. PubMed ID: 22276358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Hand dynamic injection' in electron-beam CT scanning.
    Windisch TR
    AJR Am J Roentgenol; 1994 Feb; 162(2):471. PubMed ID: 8310960
    [No Abstract]   [Full Text] [Related]  

  • 17. Venous air embolism on contrast-enhanced CT: chimera or Trojan horse?
    Bettmann MA
    Radiology; 1988 May; 167(2):571-2. PubMed ID: 3357977
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary: oral contrast medium administration for abdominal CT - reevaluating the benefits and disadvantages in the pediatric patient.
    Donnelly LF
    Pediatr Radiol; 1997 Sep; 27(9):770-2. PubMed ID: 9285746
    [No Abstract]   [Full Text] [Related]  

  • 19. [Jugular vein reflux in the CT x-ray].
    Schild H; Geier G; Schaub T
    Rofo; 1984 May; 140(5):615-6. PubMed ID: 6429772
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationales for the use of intravenous contrast medium in computed tomography.
    Albertyn LE
    Australas Radiol; 1989 Feb; 33(1):29-33. PubMed ID: 2653296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.